Roshawn A. Blunt - Jun 6, 2023 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role
Director
Signature
/s/ Jennifer P. Lam, Attorney-in-Fact
Stock symbol
RPHM
Transactions as of
Jun 6, 2023
Transactions value $
$0
Form type
4
Date filed
6/8/2023, 06:17 PM
Previous filing
Aug 2, 2022
Next filing
Jun 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPHM Stock Option (right to buy) Award $0 +14.8K $0.00 14.8K Jun 6, 2023 Common Stock 14.8K $9.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest on the earlier of June 6, 2024 or the day prior to the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.